Literature DB >> 31463972

Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node-negative papillary thyroid carcinoma without capsule invasion.

Shang-Yan Xu1, Jie-Jie Yao1, Wei Zhou1, Lin Chen1,2, Wei-Wei Zhan1.   

Abstract

BACKGROUND: To evaluate the association of preoperative clinical and sonographic features with central lymph node metastasis (CLNM) in patients with clinically node-negative (cN0) papillary thyroid carcinoma (PTC) without capsule invasion.
METHODS: Clinical and sonographic features of 635 cN0 PTC nodules without capsule invasion were retrospectively reviewed. CLNM was confirmed by pathology. Univariate and multivariate analyses were performed to analyze the predicting factors associated with CLNM in cN0 PTC without capsule invasion.
RESULTS: In the 635 cN0 PTC nodules without capsule invasion, age ≤36 years, male, tumor size >8 mm, the distance between the tumor and the capsule ≤1.1 mm and calcification were independently associated with CLNM (P < .05).
CONCLUSIONS: CLNM was associated with age, sex, tumor size, the distance between the tumor and the capsule, and calcification in cN0 PTC without capsule invasion. Preoperative assessment of risk factors could help to select PTC patients who benefit from surgery.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  metastasis; papillary thyroid carcinoma; ultrasonography

Year:  2019        PMID: 31463972     DOI: 10.1002/hed.25941

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

Review 1.  Total thyroidectomy versus thyroid lobectomy in the treatment of papillary carcinoma.

Authors:  Marco Raffaelli; Serena Elisa Tempera; Luca Sessa; Celestino Pio Lombardi; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2020-01

2.  Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.

Authors:  Zheng Zhang; Xin Zhang; Yifei Yin; Shuangshuang Zhao; Keke Wang; Mengyuan Shang; Baoding Chen; Xincai Wu
Journal:  BMC Cancer       Date:  2022-04-27       Impact factor: 4.638

3.  Dual-energy computed tomography could reliably differentiate metastatic from non-metastatic lymph nodes of less than 0.5 cm in patients with papillary thyroid carcinoma.

Authors:  Ying Zou; Meizhu Zheng; Ziyu Qi; Yu Guo; Xiaodong Ji; Lixiang Huang; Yan Gong; Xiudi Lu; Guolin Ma; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-04

4.  Ultrasound-based radiomics analysis for preoperative prediction of central and lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multi-institutional study.

Authors:  Yuyang Tong; Jingwen Zhang; Yi Wei; Jinhua Yu; Weiwei Zhan; Hansheng Xia; Shichong Zhou; Yuanyuan Wang; Cai Chang
Journal:  BMC Med Imaging       Date:  2022-05-02       Impact factor: 1.930

5.  Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).

Authors:  Xin Gao; Wenpei Luo; Lingyun He; Juan Cheng; Lu Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-27       Impact factor: 5.555

6.  Ultrasonic Characteristics Improve Prediction of Central Lymph Node Metastasis in cN0 Unifocal Papillary Thyroid Cancer.

Authors:  Yongchen Liu; Jianhao Huang; Zhiyuan Zhang; Yijie Huang; Jialin Du; Sanming Wang; Zeyu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

7.  A Comparative Analysis of Six Machine Learning Models Based on Ultrasound to Distinguish the Possibility of Central Cervical Lymph Node Metastasis in Patients With Papillary Thyroid Carcinoma.

Authors:  Ying Zou; Yan Shi; Jihua Liu; Guanghe Cui; Zhi Yang; Meiling Liu; Fang Sun
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

8.  Clinical Relevance and Management of Recurrent Laryngeal Nerve Inlet Zone Lymph Nodes Metastasis in Papillary Thyroid Cancer.

Authors:  Guibin Zheng; Guochang Wu; Haiqing Sun; Chi Ma; Yawen Guo; Dongmin Wei; Wenbin Yu; Haitao Zheng; Xicheng Song
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.